da Silva Jorge Santos
Director, Chief Executive Officer · 3 filings · Latest: Jul 9, 2026
MoonLake Immunotherapeutics
| Ticker | Owner | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Filing |
|---|---|---|---|---|---|---|---|---|---|
MLTX | da Silva Jorge Santos | Director, Chief Executive Officer | Jul 10, 2026 | Sale | $20.02 | 68,289 | $1.4M | 2,774,893 | |
MLTX | da Silva Jorge Santos | Director, Chief Executive Officer | Jul 9, 2026 | Sale | $20.01 | 33,936 | $679.1K | 2,843,182 | |
MLTX | da Silva Jorge Santos | Director, Chief Executive Officer | Jul 1, 2026 | Sale | $20.03 | 47,775 | $956.9K | 2,877,118 | |
MLTX | Santos da Silva Jorge | — | Jun 30, 2026 | Proposed Sale | $20.03 | 150,000 | $3.0M | — | |
MLTX | da Silva Jorge Santos | Director, Chief Executive Officer | Apr 13, 2026 | Sale | $18.23 | 51,873 | $945.6K | 2,924,893 | |
MLTX | da Silva Jorge Santos | Director, Chief Executive Officer | Apr 10, 2026 | Sale | $18.41 | 98,127 | $1.8M | 2,976,766 | |
MLTX | Jorge Pedro Santos Radeck D Silva | — | Apr 10, 2026 | Proposed Sale | $18.58 | 150,000 | $2.8M | — | |
MLTX | Jorge Pedro Santos Radeck Da Silva | — | Dec 8, 2025 | Proposed Sale | $14.90 | 200,000 | $3.0M | — |